ENXTAM:DSFIRChemicals
DSM-Firmenich (ENXTAM:DSFIR) Stock Rerating Hinges On Margin Rebuild Durability
DSM-Firmenich stock has quietly rerated into earnings, with the share price up about 47% over the past three months and closing at €93.38 on 31 July. Expectations were high for a business that is often treated as a premium play in fragrances, nutrition and health ingredients. The headline from this half year is about profitability. Earnings per share for H1 2026 came in at €0.86 and net income from ongoing operations reached €216m, set against a rich trailing P/E of 71.2x that already prices...